Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY

v3.23.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY - USD ($)
$ in Thousands
Common stock
Additional paid in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total
Balance at the beginning of the period, shares at Dec. 31, 2021 937,547,934        
Balance at the beginning of the period at Dec. 31, 2021 $ 1,337 $ 959,611 $ (11,142) $ (743,846) $ 205,960
Increase (Decrease) in Stockholders' Equity          
Issuance of shares upon exercise of stock options $ 5 30     35
Issuance of shares upon exercise of stock options (in shares) 3,318,072        
Other comprehensive loss     1,829   1,829
Share-based compensation expense   5,586     5,586
Net profit/(loss)       (50,265) (50,265)
Balance at the end of the period at Mar. 31, 2022 $ 1,342 965,227 (9,313) (794,111) $ 163,145
Balance at the end of the period, shares at Mar. 31, 2022 940,866,006        
Balance at the beginning of the period, shares at Dec. 31, 2022 987,109,890       987,109,890
Balance at the beginning of the period at Dec. 31, 2022 $ 1,399 990,656 (875) (909,302) $ 81,878
Increase (Decrease) in Stockholders' Equity          
Issuance of shares upon exercise of stock options $ 7 1     8
Issuance of shares upon exercise of stock options (in shares) 6,035,574        
Issuance of shares upon completion of public offering, net of issuance costs $ 1 187     188
Issuance of shares upon completion of public offering, net of issuance costs (in shares) 554,496        
Other comprehensive loss     (910)   (910)
Share-based compensation expense   1,676     1,676
Net profit/(loss)       1,036 1,036
Balance at the end of the period at Mar. 31, 2023 $ 1,407 $ 992,520 $ (1,785) $ (908,266) $ 83,876
Balance at the end of the period, shares at Mar. 31, 2023 993,699,960       993,699,960